Found 7 matching trials
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A PHASE3 The primary objectives of the study are to further evaluate the efficacy an...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A PHASE3 This study was divided into four stages: screening period, main trial perio...
Show More Location
Children's Hospital Affiliated to Chongqing Medical University
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection N/A Primary objective: To assess the pharmacokinetics of Recombinant Human Coag...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment. PHASE3 The indication for this product is to control and prophylaxis in patients w...
Show More Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A. PHASE3 The primary objectives of the study are to evaluate the efficacy of Recombi...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment PHASE3 The indication for this product is to control bleeding in patients with hem...
Show More Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ,Fc Fusion Protein for Injection PHASE1 Primary objective: To assess the pharmacokinetics of Recombinant Human Coag...
Show More Location
Beijing Children's Hospital,Capital Medical University
Learn More & Join Trial